glp-1 news today cardiovascular outcomes 2025 november ISPOR 2025: Exploring reasons for discontinuation glp-1 news today cardiovascular outcomes

Formulary tier and copay are not publicly confirmed at the drug level

CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS High salt intake is rife in modern society and has a significant impact on health

The FDA Pharmacy Compounding Advisory Committee (PCAC) began reviewing the qualification of Copper Peptide GHK-Cu Powder as a compounded drug substance in July 2026

True L-carnitine deficiency is uncommon in cats eating complete, meat-based diets, but demand can outpace supply during weight loss, illness, or some heart conditions and that is exactly when supplementation gets studied

In July 2026, an appeals court revived hundreds of these lawsuits, reversing a previous decision from a judge

Our guide on how long peptides take to work provides additional context for setting realistic expectations, and peptide before and after results from the research community illustrate the range of outcomes people experience